Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 23;37(1):41.
doi: 10.1186/s43046-025-00287-x.

Expression of VISTA on T cells in patients with cancer colon

Amira Gamal El Dein Badary  1 , Rania Bakry  2   3 , Khalid Rezk  4 , Maged Af Amine  5 , Asmaa M Zahran  2   3
Affiliations

Expression of VISTA on T cells in patients with cancer colon

Amira Gamal El Dein Badary et al. J Egypt Natl Canc Inst. .

Abstract

Colorectal cancer (CRC) is one of the most common tumors in the world. A recent area of study for the treatment of patients with solid tumors is anti-tumor immunity. PD-1/PD-L1 inhibitors were beneficial for cancer patients with multiple tumor types. However, their efficacy for CRC is low. Thus, there is an urgent need to explore additional co-inhibitory tools such as VISTA for CRC treatment.ObjectiveThe current study aimed to evaluate expression of VISTA on T cell subsets in patients with CRC and its correlation with other prognostic markers.Patients and methodsThe study included 31 patients with CRC and 25 healthy controls. All participants were subjected to full history taking, clinical examination, routine laboratory investigations, and flow cytometric detection of VISTA expression on T cell subsets on peripheral blood (PB). In addition to detection of VISTA expression on T cell subsets on tissue samples of both malignant CRC and normal colon tissue of the CRC patients.ResultsIn the peripheral blood, the expression of VISTA on CD4+ T helper and CD8+ T cytotoxic cells was significantly higher in CRC patients than the normal controls. There was no significant difference in VISTA expression on double positive T cells (CD4+CD8+) between the CRC patients and normal controls. In tissue samples, expression of VISTA on CD4 + T helper, CD8 + T cytotoxic, and double positive T (CD4 + CD8 +) cells in the malignant tissue of CRC patients was significantly higher than that in normal colonic tissue. Also, in CRC patients, the expression of VISTA on CD4+ T helper, CD8+ T cytotoxic, and double positive T cells in both malignant CRC tissue and normal colonic tissue was significantly higher than its expression PB.ConclusionThe higher expression of VISTA in CRC patients than the healthy controls and its higher levels in malignant CRC tissue and normal colonic tissue than PB of CRC patients suggest the role VISTA in the pathogenesis of CRC.

Keywords: Colorectal cancer (CRC); T cell subsets; VISTA.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study was approved by Research Ethics Committee of the Molecular Biology Research & Studies Institute (MBRSI), Assiut University, Egypt (Approval No. MB - 23 - 10 - A). Informed written consent to participate in the study was provided by all participants. Consent to participate: Written informed consent for publication of their details was obtained from all participants included in the study. Competing interests: The authors declare no competing interests.

References

    1. Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przybyłowicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel). 2021;13:2025. https://doi.org/10.3390/cancers13092025 . - DOI - PubMed
    1. Dezfuli AAZ. Abu−Elghait M, Salem SS, Recent insights into nanotechnology in colorectal cancer. Appl Biochem Biotechnol. 2024;196:4457–71. https://doi.org/10.1007/s12010-023-04696-3 . - DOI - PubMed
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660 . - DOI - PubMed
    1. Gado A, Ebeid B, Abdelmohsen A, Axon A. Colorectal cancer in Egypt is commoner in young people: is this cause for alarm? Alexandria Journal of Medicine. 2014;50:197–201. https://doi.org/10.1016/j.ajme.2013.03.003 . - DOI
    1. Elashi AA, Nair VS, Taha RZ, Shaath H, Elkord E. DNA methylation of immune checkpoints in the peripheral blood of breast and colorectal cancer patients. OncoImmunology. 2019;8(2):e1542918. - DOI - PubMed

LinkOut - more resources